Clinical Trial Update: Low-dose Colchicine for Thromboprophylaxis After Transcatheter Aortic Valve Replacement [NA]

View source ↗

Summary

A clinical trial is evaluating low-dose colchicine for thromboprophylaxis after transcatheter aortic valve replacement; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Transcatheter Aortic Valve Replacement, Transcatheter Heart Valve Thrombosis | NA | Status: NOT_YET_RECRUITING